Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideILMNIllumina, Inc.
FinDog View：Bullish
TMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | ILMN | TMO |
|---|
| Close | 276.67 | 662.24 |
| Market Cap | $42.0B | $243B |
| 1M | +34.01% | +8.60% |
| P/E (TTM) | 50.9 | 34.9 |
| Forward P/E | 42.1 | 24.6 |
| P/E 5-Yr Percentile | 98 | 66 |
| P/S | 9.4 | 5.3 |
| P/B | 14.8 | 4.6 |
| Dividend Yield | — | 0.29% |
| Latest Quarter Revenue | $1.2B | $12.0B |
| Revenue YoY | +9.4% | +10.5% |
| Gross Margin | 66.4% | — |
| Latest Quarter EPS | 1.35 | 4.68 |
| Avg Post-Earnings Move | ±8.2% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 1.29% | 2.33% |
| 90-Day Net Insider Buying | — | −$38.9M |
ILMN · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
